<div id="readability-page-1"><p>Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP David Tucker sold 704 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total value of $75,574.40. Following the completion of the transaction, the executive vice president owned 10,802 shares in the company, valued at $1,159,594.70. The trade was a 6.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this link.</p><div><p><span></span><span>Get <strong>Addus HomeCare</strong> alerts:</span></p></div><h2>Addus HomeCare Stock Down 3.3%</h2><p>Addus HomeCare stock traded down $3.58 during mid-day trading on Thursday, hitting $104.02. The company's stock had a trading volume of 269,378 shares, compared to its average volume of 239,147. The firm's 50 day moving average is $109.57 and its 200 day moving average is $113.08. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.66. Addus HomeCare Corporation has a 52-week low of $88.96 and a 52-week high of $124.43. The company has a market cap of $1.92 billion, a PE ratio of 19.97, a price-to-earnings-growth ratio of 1.26 and a beta of 0.91. </p><h2>More Addus HomeCare News</h2><p>Here are the key news stories impacting Addus HomeCare this week:</p><ul>   <li><span>Positive Sentiment: </span>Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&amp;A-driven growth strategy for 2026 — supports longer‑term earnings upside. <i></i><span>Addus HomeCare Earnings Call Highlights Growth And Scale</span></li>    <li><span>Positive Sentiment: </span>Stephens trimmed its price target from $140 to $135 but kept an &#34;overweight&#34; rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. <i></i><span>Stephens price target note</span></li>    <li><span>Neutral Sentiment: </span>Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). <i></i><span>Conference participation</span></li>    <li><span>Neutral Sentiment: </span>Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. <i></i><span>MarketBeat ADUS page</span></li>    <li><span>Negative Sentiment: </span>Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. <i></i><span>CEO insider-sale SEC filing</span></li>    <li><span>Negative Sentiment: </span>Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. <i></i><span>Short interest data</span></li> </ul><h2>Analysts Set New Price Targets</h2><p>A number of equities research analysts recently weighed in on ADUS shares. Wall Street Zen raised Addus HomeCare from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research report on Monday. Weiss Ratings  reaffirmed a &#34;hold (c+)&#34; rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Stephens lowered their target price on Addus HomeCare from $140.00 to $135.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday. TD Cowen  restated a &#34;buy&#34; rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Finally, BMO Capital Markets initiated coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They set a &#34;market perform&#34; rating and a $120.00 price target for the company. One equities research analyst  has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued  a Hold rating and one  has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $134.33.</p><p><b>Get Our Latest Stock Report on ADUS</b></p><h2>Institutional Trading of Addus HomeCare</h2><p>Institutional investors and hedge funds have recently bought and sold shares of the business. Global Retirement Partners LLC grew its stake in  Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company's stock valued at $25,000 after buying an additional 186 shares during the last quarter.  Larson Financial Group LLC grew its holdings in shares of  Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company's stock worth $28,000 after purchasing an additional 136 shares in the last quarter.  Acumen Wealth Advisors LLC bought a new position in  Addus HomeCare in the 4th quarter valued at about $29,000.  Private Trust Co. NA increased its stake in  Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company's stock valued at $30,000 after acquiring an additional 112 shares during the last quarter.  Finally, Arax Advisory Partners raised its holdings in shares of  Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company's stock worth $30,000 after buying an additional 137 shares in the last quarter. Institutional investors own  95.35% of the company's stock. </p><h2>Addus HomeCare Company Profile</h2> (Get Free Report)<p>Addus HomeCare <span>NASDAQ: ADUS<span></span></span> is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.  </p><p>The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Addus HomeCare</li><li>Read this or regret it forever</li><li>This makes me furious</li><li>The free stock picks nobody’s talking about</li><li>Elon Musk: This Could Turn $100 into $100,000</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QURVUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QURVUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Addus HomeCare Right Now?</h2><p>Before you consider Addus HomeCare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.</p><p>While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ADUS

<p>Addus HomeCare EVP David Tucker sold 704 shares at $107.35 each, totaling $75,574.40, reducing his ownership by 6.12%. Post-sale, he holds 10,802 shares valued at approximately $1.16 million. The stock is currently down 3.3% to $104.02, with a market cap of $1.92 billion. Analysts have mixed sentiments, with Stephens lowering its price target from $140 to $135 but maintaining an "overweight" rating. Insider selling has raised concerns, as CEO R. Dirk Allison and other executives sold shares recently, potentially impacting market sentiment.</p>

Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells 704 Shares of Stock